Ji, Ying
Liu, Xiangsheng http://orcid.org/0000-0002-5719-2838
Li, Juan http://orcid.org/0000-0003-4110-3295
Xie, Xiaodong
Huang, Max http://orcid.org/0000-0003-4580-1656
Jiang, Jinhong
Liao, Yu-Pei
Donahue, Timothy
Meng, Huan http://orcid.org/0000-0001-8844-3938
Funding for this research was provided by:
U.S. Department of Health & Human Services | U.S. Public Health Service (1U01CA198846)
California Institute for Regenerative Medicine (DISC2-08824)
Article History
Received: 17 August 2019
Accepted: 28 July 2020
First Online: 25 August 2020
Competing interests
: The authors declare the following competing interest(s): H.M. is co-founder, board member, and equity holder in Westwood Bioscience Inc. H.M. is also co-founder and equity holder in NAMMI therapeutics. The remaining authors declare no competing interests.